SEARCH RESULTS

RESEARCH NEWS 2017-12-13 Research News An antisense oligonucleotide knocked down levels of the mutant huntingtin protein in Huntington’s disease patients, who appeared to tolerate treatment well, according to a December 11 announcement by Ionis Pharmaceuticals, Inc., in Carlsbad ...

GRANT Wednesday, December 13, 2017- 11:30 National Institute of Neurological Disorders and Stroke NINDS intends to fund up to 12 awards, corresponding to a total of $5 million for fiscal year 2019. Future year amounts will depend on annual appropriations. ...

GRANT Wednesday, December 13, 2017- 11:15 National Institute of Neurological Disorders and Stroke The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications. Standard dates apply, by 5 p.m. ...

GRANT Wednesday, December 13, 2017- 11:15 National Institute of Neurological Disorders and Stroke The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications. Standard dates apply, by 5 p.m. ...

CONFERENCE COVERAGE 2017-12-13 Conference Coverage Advancing dementia can bring with it psychosis, which greatly adds to the burden of life with Alzheimer’s disease for both the sufferer and his or her carers. No drugs are approved to treat dementia-related psychosis. Used off-label, ...